X-Site Seeks Financing, Possible Partner For Vascular Closure System Launch
This article was originally published in The Gray Sheet
Executive Summary
X-Site Medical is pursuing additional financing to support commercialization of its recently approved X-Press 6 Fr. vascular closure system
You may also be interested in...
Abbott StarClose Opens Vascular Closure Options; U.S. Launch Set For 2005
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.